Goldman Sachs Group Inc Alvotech Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Alvotech stock. As of the latest transaction made, Goldman Sachs Group Inc holds 25,871 shares of ALVO stock, worth $330,631. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,871Holding current value
$330,631% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ALVO
# of Institutions
41Shares Held
14.6MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.2MShares$40.9 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$34.6 Million5.53% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.93MShares$24.6 Million0.65% of portfolio
-
Morgan Stanley New York, NY1.74MShares$22.2 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$16.9 Million7.91% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $3.18B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...